New Health Care Advisory Committee Established To Help HHS And CMS

The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) announced the members of the Healthcare Advisory Committee, a new federal advisory body that will provide expert advice on improving, strengthening and modernizing U.S. health care.

The committee will advise HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz on ways to improve how care is financed and delivered across Medicare, Medicaid, the Children’s Health Insurance Program, and the Health Insurance Marketplace.

“This Administration is bringing leaders together to tackle the challenges facing American patients and the health care system, putting prevention front and center,” said HHS Secretary Robert F. Kennedy, Jr. “This committee will help us shift from a sick care system to a true health care system by delivering practical solutions that drive real change.”

“We received an overwhelming response from highly qualified candidates across the country,” said CMS Administrator Dr. Mehmet Oz. “These members bring deep expertise across care delivery, financing, innovation, and patient engagement. Their insights will help us advance higher-quality care, reduce administrative burden, and strengthen the sustainability of our programs, while supporting efforts to transform our health care system and restore a stronger focus on patients.”

The committee will provide non-binding recommendations to inform federal health care policy and program administration.

  • Over its term, the committee will focus on:
  • Developing actionable policy solutions to prevent and better manage chronic disease
  • Advancing accountability for safety and outcomes while reducing unnecessary administrative burden
  • Expanding the use of real-time data to support a higher quality of care, speed up claims processing, and improve quality measurement
  • Enhancing care for vulnerable populations, including those served by Medicaid
  • Strengthening Medicare Advantage sustainability, including modernizing risk adjustment and quality measurement

Members will serve two-year terms and will meet regularly throughout the year, with meetings open to the public consistent with federal transparency requirements. The Committee is authorized under the Public Health Service Act and operates in accordance with the Federal Advisory Committee Act.

The following individuals will serve on the committee:

  • Robert Bessler, MD
  • Kimberly Brandt, JD (ex officio)
  • Sebastian Caliri
  • Stephanie Carlton (ex officio)
  • David Carmouche, MD
  • Elizabeth M. Fago
  • Clive K. Fields, MD
  • William J. Gassen, JD
  • Jenni Gudapati, PhD
  • Valerie D. Huhn
  • Dennis Laraway
  • Dan Liljenquist, JD
  • Andrew Lynch, PhD
  • Ursel J. McElroy
  • Kyu Rhee, MD
  • Tony Robbins
  • Russ Thomas, JD

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square